Apeloa Pharmaceutical Co.,Ltd. (000739) has announced that its wholly owned subsidiary, Zhejiang Apeloa Jiayuan Pharmaceutical Co., Ltd., has received a Notice of Approval for the Marketing Application of the Chemical Active Pharmaceutical Ingredient for deuterated enzalutamide, issued by the National Medical Products Administration.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.